Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents.
Dominic PilonZhijie DingErik MuserAmeur M ManceurMaude Vermette-LaformeMarie-Hélène LafeuillePatrick LefebvrePublished in: Crohn's & colitis 360 (2022)
Among CD patients, suboptimal treatment indicators were common and were associated with an increased burden to the healthcare system.